BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31018022)

  • 1. Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.
    Duijvesz D; Rodriguez-Blanco G; Hoogland AM; Verhoef EI; Dekker LJ; Roobol MJ; van Leenders GJLH; Luider TM; Jenster G
    Prostate; 2019 Jun; 79(9):1032-1042. PubMed ID: 31018022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
    Duijvesz D; Burnum-Johnson KE; Gritsenko MA; Hoogland AM; Vredenbregt-van den Berg MS; Willemsen R; Luider T; Paša-Tolić L; Jenster G
    PLoS One; 2013; 8(12):e82589. PubMed ID: 24391718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
    Fujita K; Kume H; Matsuzaki K; Kawashima A; Ujike T; Nagahara A; Uemura M; Miyagawa Y; Tomonaga T; Nonomura N
    Sci Rep; 2017 Feb; 7():42961. PubMed ID: 28211531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer.
    Cao Z; Xu Y; Guo F; Chen X; Ji J; Xu H; He J; Yu Y; Sun Y; Lu X; Wang F
    Dis Markers; 2020; 2020():3904947. PubMed ID: 32655718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry.
    Biggs CN; Siddiqui KM; Al-Zahrani AA; Pardhan S; Brett SI; Guo QQ; Yang J; Wolf P; Power NE; Durfee PN; MacMillan CD; Townson JL; Brinker JC; Fleshner NE; Izawa JI; Chambers AF; Chin JL; Leong HS
    Oncotarget; 2016 Feb; 7(8):8839-49. PubMed ID: 26814433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
    Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
    Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Proteome of Primary Prostate Cancer.
    Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
    Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.
    Carleton NM; Zhu G; Gorbounov M; Miller MC; Pienta KJ; Resar LMS; Veltri RW
    Prostate; 2018 May; 78(7):547-559. PubMed ID: 29520928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies.
    Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling in tissues and urine of patients with prostatic lesions and the diagnostic value of urine extracellular vesicles metabolites in prostate cancer.
    Ding T; He W; Yan H; Wei Z; Zeng X; Hao X
    Clin Chim Acta; 2024 Mar; 556():117845. PubMed ID: 38403146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
    Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
    Cao W; Li F; Yao J; Yu J
    BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.
    Zhang H; Qi C; Wang A; Yao B; Li L; Wang Y; Xu Y
    J Exp Clin Cancer Res; 2013 Oct; 32(1):77. PubMed ID: 24422979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endosomal gene expression: a new indicator for prostate cancer patient prognosis?
    Johnson IR; Parkinson-Lawrence EJ; Keegan H; Spillane CD; Barry-O'Crowley J; Watson WR; Selemidis S; Butler LM; O'Leary JJ; Brooks DA
    Oncotarget; 2015 Nov; 6(35):37919-29. PubMed ID: 26473288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death.
    Mortezavi A; Salemi S; Rupp NJ; Rüschoff JH; Hermanns T; Poyet C; Randazzo M; Simon HU; Moch H; Sulser T; Wild P; Eberli D
    Oncotarget; 2017 May; 8(19):31765-31774. PubMed ID: 28423666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmitoylation is a post-translational modification of Alix regulating the membrane organization of exosome-like small extracellular vesicles.
    Romancino DP; Buffa V; Caruso S; Ferrara I; Raccosta S; Notaro A; Campos Y; Noto R; Martorana V; Cupane A; Giallongo A; d'Azzo A; Manno M; Bongiovanni A
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2879-2887. PubMed ID: 30251702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer.
    Signore M; Alfonsi R; Federici G; Nanni S; Addario A; Bertuccini L; Aiello A; Di Pace AL; Sperduti I; Muto G; Giacobbe A; Collura D; Brunetto L; Simone G; Costantini M; Crinò L; Rossi S; Tabolacci C; Diociaiuti M; Merlino T; Gallucci M; Sentinelli S; Papalia R; De Maria R; Bonci D
    Cell Death Dis; 2021 Jun; 12(7):636. PubMed ID: 34155195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tSTAT3, pSTAT3
    Krzyzanowska A; Don-Doncow N; Marginean FE; Gaber A; Watson RW; Hellsten R; Bjartell A
    Prostate; 2019 May; 79(7):784-797. PubMed ID: 30905090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.